GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Suraksha Diagnostic Ltd

Suraksha Diagnostic: Board Meeting to Consider FY26 Results & Dividend

BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 13 May 2026, 05:59 PM IST  ·  BSE ID: 5b268b99-efdf-4f7a-a223-d5ec4c3e3af4
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board will meet on May 21, 2026, to review its financial results and potentially declare a dividend.
🤖 AI Summary
  • Suraksha Diagnostic's Board meeting scheduled for Thursday, May 21, 2026
  • Meeting to consider and approve audited financial results for Q4 FY26 and FY26
  • Board will consider recommendation of dividend on equity shares for FY26
  • Trading window closed from April 01, 2026, re-opens 48 hours after results
  • Disclosure pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this intimation.
👤
Who Is Affected
Shareholders are indirectly affected as the upcoming Board meeting will determine the company's financial performance disclosure and potential dividend, which impact equity share value.
🔍
Management Signal
Management is adhering to regulatory requirements by intimating the Board meeting for financial results approval and dividend consideration.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Board Meeting Outcome on May 21, 2026 — check for financial results release
Audited financial results for FY26 — analyze revenue and profit figures
Dividend recommendation — confirm if a dividend has been proposed
LOW RISK The filing is a routine intimation of a scheduled Board meeting, presenting no immediate specific risks.
💡 Investor Takeaway
Suraksha Diagnostic's Board is set to meet on May 21, 2026, to approve financial results for the quarter and financial year ended March 31, 2026. A potential dividend recommendation for FY26 will also be considered by the Board.
You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.